Table 1.
AUS cohort | UK cohort | p value | |
---|---|---|---|
Patients | N = 570 | N = 2755 | |
Eyes | N = 647 | N = 3187 | |
Mean [SD] age in years | 78.49 [6.76] | 77.96 [8.14] | 0.6573 |
Proportion of patients per age group at index date in % | 0.0027 | ||
<65 years | 3.40 | 6.46 | |
65–69 years | 9.58 | 6.78 | |
70–74 years | 12.67 | 12.52 | |
75–79 years | 19.17 | 21.65 | |
80–84 years | 36.01 | 32.44 | |
≥85 years | 19.17 | 20.14 | |
Gender (patient) in % | 0.0312 | ||
Female | 57.82 | 63.67 | |
Male | 42.18 | 36.33 | |
VA study eye (eye) | 0.1979 | ||
N | 647 | 3187 | |
Mean [SD], letters | 54.89 [18.82] | 55.05 [15.59] | |
VA fellow eye (eye) | <0.0001 | ||
N | 273 | 2883 | |
Mean [SD], letters | 65.19 [18.56] | 59.65 [23.86] | |
VA functional groups (eye) | |||
>70 letters | 21.48 | 17.29 | |
56–70 letters | 31.84 | 33.51 | |
35–55 letters | 34.47 | 37.68 | |
<35 letters | 12.21 | 11.52 |
AUS Australia, N number of eyes, SD standard deviation, VA visual acuity